Inhouse product
Indications
Zeroflux is indicated
in-
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Pharmacology
This is the
combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an
alginate (Sodium alginate). The suspension work in two ways-
The mode of action of
the product is physical and does not depend on absorption into the systemic
circulation. The product is a combination of two antacids (Calcium Carbonate
and Sodium Bicarbonate) and an Alginate. On ingestion, the medicinal product
reacts rapidly with gastric acid to form a raft of Alginic Acid gel having a
near neutral pH and studies have shown that the raft interacts with and caps
the acid pocket in the stomach, reducing esophageal acid exposure. The raft
floats on the stomach contents effectively impeding gastro-esophageal reflux,
for up to 4 hours, and protecting the esophagus from Acid, Pepsin and Bile.In
severe cases the raft itself may be refluxed into the esophagus, in preference
to the stomach contents, and exert a demulcent effect. In addition in vitro
evidence has shown that the raft has a secondary action and is able to entrap
bile and pepsin within it structure, further protecting the esophagus from
these gastric components. Calcium Carbonate neutralizes gastric acid to provide
fast relief from indigestion and heartburn.This effect is increased by the
addition of Sodium Bicarbonate which also has a neutralizing action.
Dosage & Administration
For oral suspension:
Chewable Tablet should
be taken in oral route after being thoroughly chewed. Recommended dose:
Hepatic Impairment: No dose modification necessary.
Renal Insufficiency: Caution if highly restricted salt diet is
necessary.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Interaction
A time-interval of 2
hours should be considered between Zeroflux intake and the administration of
other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone,
Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers
(Atenolol, Metoprolol, Propranolol), Glucocorticoid, Chloroquine and
Biphosphonates (diphosphonates) and Estramustine.
Contraindications
This product is
contraindicated in patients with known or suspected hypersensitivity to the
active ingredients or to any of the excipients.
Side Effects
In addition to the
desired effect of the drug, some side effects may appear such as: constipation,
flatulence, stomach cramp or belching. In these cases consult a physician. If
too big dose has been taken, there might appear a sensation of swelling. In
this case, it is advisable to consult a physician.
Pregnancy & Lactation
Pregnancy: Clinical studies in more than 500 pregnant
women, as well as a large amount of data from post-marketing
experience, indicate no malformative nor feto/neonatal toxicity of the
active ingredients. This drug can be used during pregnancy, if clinically
needed.
Breastfeeding: No effects of the active substances have
been shown in breastfed newborns/infants of treated mothers. This drug can be
used during breastfeeding.
Fertility: Pre-clinical investigations have revealed
Alginate has no negative effect on parental or offspring fertility or
reproduction. Clinical data do not suggest that this drug has an effect on
human fertility.
Precautions & Warnings
Each 20 ml of dose has
a sodium content of 254.5 mg (11.06 mmol). This should be taken into account
when a highly restricted salt diet is recommended, e.g. in some cases of
congestive cardiac failure and renal impairment.
Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in
treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium
containing renal calculi.
Treatment of children younger than 12 years of age is not generally
recommended, except on medical advice.
Zeroflux is considered high in sodium. This should be taken into account when a
highly restricted salt diet is recommended, e.g., in some cases of congestive
cardiac failure and renal impairment. Each tablet contains 75 mg of calcium.
Care needs to be taken in treating patients with hypercalcaemia,
nephrocalcinosis and recurrent calcium containing renal calculi. Due to its
aspartame content Zeroflux should not be given to patients with
phenylketonuria. If symptoms persist, or treatment is required for more than 7
days continuously, medical advice should be sought. Taking Zeroflux can mask
the symptoms of other more serious, underlying medical conditions. It should
not be used in patients with impaired renal function/insufficiency and with
hypophosphatemia. This may cause allergic reactions.
Overdose Effects
In the event of over
dosage symptomatic treatment should be given. The patient may notice abdominal
distension.
Therapeutic Class
Antacids
Storage Conditions
Store in a cool (below
30°C) and dry place, away from light. Keep out of the reach of children. Do not
refrigerate or freeze.
Common Questions about Zeroflux (500 mg+267
mg+160 mg)/10 ml Suspension
What is Zeroflux (500 mg+267 mg+160 mg)/10 ml
Suspension?
Zeroflux (500 mg+267
mg+160 mg)/10 ml Suspension is the combination of two antacids and an alginate.
This is commonly used to treat Gastric reflux, Heartburn, Indigestion,
Flatulence associated with gastric reflux.
Is Zeroflux (500 mg+267 mg+160 mg)/10 ml Suspension
safe in pregnancy?
You can take Zeroflux
(500 mg+267 mg+160 mg)/10 ml Suspension if you are pregnant or breast-feeding.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Login Or Registerto submit your questions to seller
No none asked to seller yet